Funding Opportunities
Now Accepting Applications
Developmental Projects in HIV/AIDS Malignancies Research
The University of Miami Miller School of Medicine Center for AIDS Research (CFAR) in collaboration with the Viral Oncology Program of the Sylvester Cancer Center is requesting applications for developmental projects in HIV/AIDS Malignancies research that will be funded through a competitive award recently received by the UM CFAR from the NCI Office of HIV/AIDS Malignancies (OHAM) with additional support from SCCC.
Purpose
This program is to provide pilot funds to stimulate innovative high impact research in HIV/AIDS Malignancies (both in AIDS-defining and Non-AIDS defining) and new collaborations between basic, translational or clinical researchers from the Miami CFAR and the SCCC for development of preliminary data for peer-reviewed research applications.
This program honors the vision of the late Dr. Bill Harrington, founder of the Miami CFAR AIDS Malignancies Program, in promoting AIDS-Malignancies collaborative research between the CFAR and the SCCC and with International Sites. Programmatic interests include both current scientific focus and emerging areas: 1) Molecular, cellular and genetic approaches to understand mechanisms of oncogenesis and immune evasion by the human oncogenic viruses EBV. KSHV, HPV, HCV, in the context HIV/AIDS 2) Pathogenesis-driven discovery and preclinical testing of novel therapeutic approaches for virally induced AIDS Malignancies 3) Role of HIV, HIV-induced immunopathogenesis in AIDS Malignancies 4) Use of genomic, Next-Gen/ RNAseq and systems biology approaches in AIDS Malignancies for biomarker identification and pathogenesis studies 5) Effects of HAART and anti-cancer therapies in HIV and KSHV/EBV pathogenesis and persistence 6) Local and International studies of prevention, diagnosis and treatment of virally induced AIDS-Malignancies in special populations and resource poor settings. 7) Prevention, Diagnosis and treatment of Non-AIDS defining cancers affecting long term HIV-infected population 8) International collaborations in AIDS Malignancies Research.
Funds Available
Individual applicants (this should include at least a PI and Co-PI from the CFAR or the SCCC) may apply for up to $50,000. Multi PI projects may apply for up to $75,000 in total cost. Funds can be budgeted over a one or two year period.
Eligibility
Faculty member eligibility includes investigators new to HIV/AIDS AIDS Malignancies research, newly recruited or newly promoted faculty, or junior faculty at the assistant professor. Established HIV/AIDS Malignancies investigators are eligible if they are entering an area of study new to them, if they are collaborating with a junior investigator or if this is an unfunded new area of collaboration with a SCCC Investigator. All projects should be collaborative in nature. They should involve at least two labs and they should include either as Co-PI or MPI a member of the CFAR, and a member of SCCC. International collaborative groups from new or existing collaborations with scientists from the Miami CFAR and/or the SCCC are encouraged to apply.
*Post-doctoral fellows and Research Associates *can apply as Co-PI of their mentors and the application fulfills the collaborative criteria described above.
Investigators with current NIH funding for HIV research are eligible. Women and Minorities are encouraged to apply.
Please send Letter of Intent indicating project title, CFAR and SCCC, PIs and Co-PIs by May 7th
The application deadline has been extended to May 20, 2013
Contact for guidelines and application forms:
Quita Nimrod
Miami CFAR Administrator
Email: cfar@med.miami.edu
Phone: (305) 243-8215
Awardees
Sylvester Braman Family Breast Cancer Institute Women’s Cancer League Developmental Grant
The Sylvester Comprehensive Cancer Center is pleased to announce this year’s Sylvester Braman Family Breast Cancer Institute Women’s Cancer League Developmental Grant Program awardees.
Congratulations to the 2012 awardees:
- Eli Avisar, MD, Department of Surgery, “Pilot Study of a Novel Intraoperative Imaging Technique to Identify Positive Margins in Breast Cancer Surgery”
- Anthony Capobianco, PhD, Department of Surgery, “Exploitation of the Notch Pathway to Develop Novel Anti-Cancer Therapeutic Agents”
- Mark Stoutenberg, PhD, MSPH, Department of Epidemiology and Public Health, “Use of a DVD-based Exercise Program in Breast Cancer Survivors: A Pilot Study”
Special thanks to all the applicants and reviewers that participated during the award process.
American Cancer Society Institutional Research Grant (ACS IRG)
Sylvester Comprehensive Cancer Center is pleased to announce the most recent American Cancer Society Institutional Research Grant (ACS IRG) awardees.
These grants provide funds for meritorious cancer research that cannot be readily supported through other funding mechanisms. The primary purpose of the ACS IRG Pilot Projects Grant is to provide seed funds for the initiation of promising new projects or novel ideas by junior faculty members.
Congratulations to the 2012 awardees:
- Barry Hudson, Ph.D., Department of Endocrinology, Diabetes & Metabolism for, “The Role of RAGE-Signaling in Cancer Progression and Metastasis”
- Matthew Abramowitz, M.D., Department of Radiation Oncology for, “Phase II Trial Using Erbitux+ Taxotere with Low Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma”
- Fangliang Zhang, Ph.D., Department of Molecular & Cellular Pharmacology for, “A Novel Arginylation-Dependent Proteolytic Processing of Talin in Cadherin-Mediated Cell-Cell Adhesion”
Special thanks to all the applicants and reviewers that participated during the award process.
Funding Newsletter
The monthly Funding Newsletter compiles information on local and national awards/grants for doctors and researchers. Included are NIH notices, foundation and other sources, program announcements, and requests for applications.